Take a look at the FDA Application Approvals 2000-2008 visualization (created by user mktlgcs) over at IBM’s Many Eyes to get an aerial view on the US. pharmaceutical industry.
This is a golden day for 23andMe despite all crisis worries: Mountain View, CA (PRWEB) October 30, 2008 — TIME Magazine announced today that the Personal Genome Service™ from 23andMe, Inc. has been named 2008’s Invention of the Year. 23andMe was chosen as the year’s most significant invention for its exceptional work in making personal… Continue reading Golden day for 23andMe: Time’s 2008 Invention of the Year
Michael Kingsley – diagnosed with Parkinson disease at the age 42 – wrote an utterly fatalist, sad&straight and death conscious essay entitled Mine Is Longer than Yours on the last boomer game he calls competitive longevity published in the New Yorker. This piece is the dark counterpart of the recent Wired Kurzweil coverage on Mr.… Continue reading Michael Kingsley on competitive, bitter, boomer longevity
Leaving New Orleans for the Bay Area for the next 3 days. I am visiting a quite enigmatic workshop in Palo Alto on Feb 22, then I am in San Francisco downtown on Friday evening and Saturday AM. If anybody would like to meet me, I am available there on Saturday near Union Square, just… Continue reading Off to Palo Alto, CA
In the unique state of California there is now an offer for individuals to place orders from October 3 during a $250 million sale of state debt to fund embryonic stem-cell research. The minimum bet is $5,000 and over 1 million you need special permission (just like buying more than 2 iPhones in the early… Continue reading United State of California: buy bonds in stem cell research
Quick storytelling through citations (alert from Jim Hardy, thanks): Cell: Nutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell Survival A major cause of cell death caused by genotoxic stress is thought to be due to the depletion of NAD+ from the nucleus and the cytoplasm. Here we show that NAD+ levels in mitochondria remain at physiological levels… Continue reading “Mitochondrial Oasis Effect”: fasting => NAD+ up in mitos => cell survival
Although I have no time now to meditate on NIH policies (I must take care of my cells), but I spread this package from Tom further, as the timing seems good, especially what concerns stem cell research. 4 rules (1 abandoned by me), and 1 copy/paste. 1. Include in your post the links to the… Continue reading Reconfigure the NIH!
I’ve already made some hints here, but now it is “official”: we (the new family) are moving to New Orleans on the 16th, June and I start my first postdoc job in a terrific laboratory I’ve already visited back in March. We have only one problem left: finding a proper appartment in New Orleans from… Continue reading Moving to New Orleans, starting a new life…and finding an apartment
Check out Business 2.0’s 100 fastest growing tech companies and read the excellent little summaries on the first 25 out of which 5 are medical related. In regenerative medicine LifeCell has a high position with competitors like Genentech (here think about the recent 23andMe story), Amgen Inc, Gilead Sciences.
When Hurricane Katrina came in, many researchers left Tulane University. Many efforts have been made since then to reestablish the strong academic research community. These are exactly the times, when new people with new drives enter. The following sentences are from the letter of Laura S. Levy Professor of Microbiology and Immunology and Associate Senior… Continue reading Rebuilding mentality at Tulane University, New Orleans
This extrapolation is from the inforich and insider Stem Cell Market Analysis Fact Sheet of the 2nd Annual Stem Cell Summit, February 12-13 at San Diego, happening now. Other important facts concerning the Stem Cell Therapy Market in the U.S.:
Al Gore’s Inconvenient Truth, a movie-long effective presentation on climate change and crisis has made him the chief environmental evangelist of U.S. Incorporation. (I liked that he is doing his Keynotes himself, my Apps.) Now I have a better offer for Al Gore: be the first networking-presentation man of healthy life extension and an official… Continue reading Hey Al Gore: switch to life extension, aging is a more inconvenient truth
Links I enjoyed recently all from mainstream media: San Fransisco Chronicle: THE LOST TAPES Conversations tape-recorded in the early years with Google’s founders illuminate how their actions forged the growth of a Silicon Valley giant via Philipp Lenssen’s blog. New York Magazine: The Death of (the Idea of) the Upper East Side by Jay McInerney… Continue reading Whatbox, Upper Lost Side, Stem Cell Connect-icut (weekend back links)
The first official issue of the new biological video protocol site JoVE or Journal of Visualized Experiments will be available today 11 pm EST, November 30, 2006. The graph shows November traffic in term of unique visitors, first 2.5 weeks mainly uploaders, authors, editors and editors’ friends used the page, from 17th there was a… Continue reading JoVE stats: blogosphere and Nature News traffic before official launch
In science you can always correct yourself. In stem cell research it is of utmost importance to correct what you’re claiming, if you’ve claimed it not accurately enough before. Now in November 23 Nature magazine the Lanza group has a corrected manuscript on Human embryonic stem cell lines derived from single blastomeres on the possibility… Continue reading hESCs derived from single blastomere by Lanza et al.: second trial in Nature with success
And now for something completely different! Sometimes life is just simply life for me without any extension. This is Life.exe. So at the weekends during the largely dead webtimes, I’ll blog about other things than stem cells, regenerative medicine, maximum life extension and biotech. This week offstory is a report, which shows the transformation of… Continue reading Valley Brats in Rolling Stone’s Tech Issue: trends in journalism (weekend off)
Nature News has an article of the new Journal of Visual Experiments website, whereof Pimm had a story one week ago with the help of Moshe Pritsker, founder of the site. The title of the Nature News post: YouTube for test tubes, which sounds good really, but is problematic a little bit. In a way… Continue reading Nature News on JoVE: is JoVE really the YouTube for life scientists?
David A Kekich is a heavyweight venture capitalist and investment expert. In 1999, he founded the Maximum Life Foundation, a corporation dedicated to curing aging related diseases. His LIVES™ financial strategy will finance the research needed to profitably develop life extending technologies. Kekich, who is also a lifestyle life extensionist, and very aware of current… Continue reading Maximum Life CEO David Kekich: the investment strategy of life extension
James Clement is an attorney and serial entrepreneur. He is the Chief Operating Officer of Maximum Life Foundation which supports aging and life extension research with a mature and secure VC fund strategy (next blogterviewee, David Kekich, C.E.O. of MaxLife). 1. What is the story of your life extension commitment? I have been interested in… Continue reading Maximum Life’s James Clement: what can a lawyer do for life extension?
At last there is an almost perfect solution for life scientists to share video protocols and insider tricks to learn techniques and repeat experiments properly. Journal of Visualized Experiments (JoVE) is a newly founded and FREE online research journal that publishes video-articles on biological experiments (video-protocols). It is an independent project by 2 people, Moshe… Continue reading Biological Video Protocols on JoVE: Online Journal of Visualized Experiments
Kevin Dewalt is an American technology professional, presently working at a VC. Kevin is a strong life extension supporter. We’ve met online at Baris Karadogan’s blog. I specially liked his “happy argument” for maximum life extension on the psychological level, see answer 3. 1. What is the story of your life extension commitment? When I… Continue reading Kevin Dewalt’s answers: technology professional, lifestyle life extensionist
John Cumbers made the Drosophila CHiP protocol video. He is a graduate student at the Tatar lab in Brown University, USA. Below are his answers to the blogterview questions and through answer 5 you can take a fresh look at the bottom-up approach of synthetic biology.
The spectrum of the life extension blogterviewees is broad: scholars, activists, IT people, VC folks, … and is broadening further. Here are 2 more activists/bloggers who put their answers to their blog: Anne Corwin and the aphoristically dense Phil Bowermaster. Thanks for answering. I ‘d like to emphasize that I modified questions 4-5, and introduced… Continue reading 2 more bloggers’ answers: Anne Corwin and Phil Bowermaster
Check this fresh Wired review about US Midterm elections’ effects on high-tech possibilities for the United States: In New York, Attorney General Eliot Spitzer‘s gubernatorial victory was no surprise, but it’s a big win for stem-cell research in that state. Spitzer wants to commit several billion dollars of the state’s money to the science. Link… Continue reading Election perspectives in tech support: New York City as California’s rival in stem cell billions?
There was a very interesting comment dialogue last week apropos of Aubrey de Grey‘s TED talk, and the host was Baris Karadokan’s blog called From Istanbul to Sand Hill Road subtitled High-tech, venture capital, creativity and innovation. Here are some details. Link storytelling idea source
It’s time for you to register to the North Carolina Science Blogging Conference, January 20, 2007, organized by BlogTogethter wiki. I hope that it will be a nice Unconference too.
Briefly: A lot. As you might have noticed, for me as biotechnologist/life extensionist, the most important reference group is the group of IT people, because of the engineering approach, software-hardware tools, intuition concerning technology and funds. After Reason and Chris, our next answerer is Jim Craig, who published his answers here as a comment first… Continue reading The bioinformatics bet: what can IT folks do for life extension?
Here is Chris’ answer to question 4, for me it was the most important because of its critical edge. Question 2 was about moderate or maximum life extension commitment and the question below is not restricted to maximum LE and unlimited lifespan but includes modest trials too. 4. What is the most probable technological draft… Continue reading Blogterview with Ouroboros’ Chris Patil, II.: the technology of life extension
Anne Corwin, technological progressive from California wrote a nice philosophical essay, called What Is Meant By “Rational Longevity”, in which she delineates the territory of the new buzzword referring to clear critical principles:
There is a dense comment debate on Bodyhack for more than a week concerning the electoral Missouri Stem Cell Hunter issue, celebs with ESC pro- or contra ads. Here is an effective comment from today’s related post by the commenter named Orrin: “I wonder what would happen if Bill Gates invested 2 billion dollars to… Continue reading What would happen if Bill Gates invested 3 billion dollars to embryonic stem cell research?
The term ‘Stem Cells’ eventually stepped out its scientific home and became the viral name of a music-performance group. Hear their Human Stem Cell Audio Therapy blabla from their website transmitted to audio by me via Odeo: [odeo=http://odeo.com/audio/2234526/view] Anyway, I offer the next music names for future generations: Tissue Engineers, DJ RegMed, MC Growth Factor,… Continue reading Stem Cells get viral and part of the pop culture: The Stem Cells – live
Dr. Robert Lanza, vice president of Research and Scientific Development for Worcester-based Advanced Cell Technology (ACT), will be honored at the 11th annual Mass High Tech All-Stars Awards Networking Reception on Wednesday at the category biotechnology. Link Lanza is a key person in American human embryonic stem cell technology. Some public rearguard actions of the… Continue reading New England All-Stars Award goes to Advanced Cell’s Lanza
As time goes by stem cells not just become more and more political, but a part of pop culture beyond the scientific experiments.
Hello everybody, let me introduce myself: I am the first full-time biotechnologist at Google Inc. (well, not really). My job at Google is fascinating: I have to plan and build a comprehensive regenerative database/map of the complete human body which will be the input of the ultimate human regenerative software. It is so, because in… Continue reading First full-time biotech employee at Google BioLabs
At 13th, October, a daylong event, the Stem Cell Leadership Summit Friday was organized by AAAS in Cambridge, US. Some quotes worth mentioning: The controversial Lawrence H. Summers, former Harvard president: “we are not alone in seeing the enormous impact biomedical research in general, and stem cell science in particular, will have on the region… Continue reading Brutal competition in stem cell research: Harvard fears
One previous post of Pimm was about the advantages of online, open source-like science protocol videos. So thanks to Sri Kosuri, here is an early sample protocol movie (3 parts) made by John Cumbers on the preparation of fixed chromatin from Drosophila embryos to use the DNA in a genomic array technology, developed in Rob… Continue reading Early science protocol video: OpenWetWare Drosophila CHiP
Dina Gould Halme and David A. Kessler wrote an article, called FDA Regulation of Stem-Cell–Based Therapies in The New England Journal of Medicine. The key concerns are: i., Stem-cell–based products as therapeutic agents are or could be: biologic products, drugs, devices, xenotransplantation products, human cells, tissues, and cellular and tissue-based products. Human cells, tissues, and… Continue reading FDA Stem Cell Therapy Regulation: the Framework
John Hlinko, veteran internet grass-roots organizer has launched a website called StemCellCandidates to highlight — and facilitate donations for — the races in which the stem cell issue is most likely to tip the scales. Hlinko is also the man behind StemPac, a U.S. stem cell research supporting coaliton, which includes professional political consultants, scientists… Continue reading Stem Cells’ growing role in U.S. politics: StemCandidates meet Pacman
For the first time Quantum Grant goes for international research initiative to regenerate damaged brain cells and blood vessels for the treatment of stroke which occurs when an artery in the brain is blocked. The three-year, $2.9 million grant, funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the NIH, will… Continue reading $2.9 million NIH Quantum Grant for Neuro-Vascular Regeneration to help stroke patients